Search
Takeda Pharmaceutical Co Ltd
TAKAdd to Watchlist
16.460USD
-0.180-1.08%
Close 05/08, 16:00（ET）Quotes delayed by 15 min
52.95BMarket Cap
71.66P/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.08%
5 Days
-0.96%
1 Month
-11.79%
6 Months
+20.50%
Year to Date
+5.58%
1 Year
+15.35%
TradingKey Stock Score of Takeda Pharmaceutical Co Ltd
Currency: USD Updated: 2026-05-08Key Insights
Takeda Pharmaceutical Co Ltd's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 53 out of 156 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 20.80.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Takeda Pharmaceutical Co Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Takeda Pharmaceutical Co Ltd Highlights
StrengthsRisks
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 287.84%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 287.84%.
Overvalued
The company’s latest PE is 71.66, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 86.12M shares, decreasing 9.45% quarter-over-quarter.
Held by Mairs and Power
Star Investor Mairs and Power holds 17.58K shares of this stock.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
20.800
Target Price
+25.60%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Takeda Pharmaceutical Co Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Takeda Pharmaceutical Co Ltd Info
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
Ticker SymbolTAK
CompanyTakeda Pharmaceutical Co Ltd
CEOWeber (Christophe)
Websitehttps://www.takeda.com/
Related Instruments
-2.72%
-0.53%
-0.57%
+0.44%
+0.18%
-0.82%
+0.79%
-2.04%
+0.59%
-3.02%
-0.16%
+1.13%
+0.30%
-0.18%
-2.47%
+0.82%
0.00%
-0.65%
-0.88%Popular Instruments
92.193
-2.977 (-3.13%)
293.320
+5.880 (+2.05%)
215.200
+3.700 (+1.75%)
4714.280
+29.030 (+0.62%)
480.000
+16.090 (+3.47%)
1562.340
+222.380 (+16.60%)
746.810
+100.180 (+15.49%)
400.800
+2.810 (+0.71%)
80281.260
+178.170 (+0.22%)
428.350
+16.560 (+4.02%)
